Takeda Pharmaceutical (TAK) Divestments (2018 - 2026)

Takeda Pharmaceutical's Divestments history runs 9 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• On a quarterly basis, Divestments fell 95.43% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $228.7 million, a 69.16% increase from a year earlier, with the FY2026 full-year figure at $221.4 million, up 64.05% from the prior year.
• Divestments fell to $3.3 million in Q1 2026 per TAK's latest filing, from $20.6 million in the prior quarter.
• Across five years, Divestments topped out at $224.2 million in Q1 2022 and bottomed at -$48471.0 in Q3 2023.
• The 5-year median for Divestments is $19.7 million (2024), against an average of $60.2 million.
• Across the five-year window, Divestments soared 74636.55% in 2024 and slumped 95.43% in 2026, its largest moves.
• Year by year, Divestments stood at $224.2 million in 2022, then plunged by 100.02% to -$48471.0 in 2023, then surged by 17198.88% to $8.3 million in 2024, then surged by 148.14% to $20.6 million in 2025, then slumped by 84.03% to $3.3 million in 2026.
• Per Business Quant, the three latest TAK Divestments figures stand at $3.3 million (Q1 2026), $20.6 million (Q4 2025), and $2.4 million (Q3 2025).